Grifols Therapeutics

Write a Review919-316-2060

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatment for people with life-threatening disorders. The company s wholly owned subsidiary, Talecris Plasma Resources, is a national network of plasma collection centers that provides the source material for the production of critical care protein therapies. Talecris Biotherapeutics employs more than 4,300 people worldwide. The company is licensed to do in-house nucleic acid testing for hepatitis C, hepatitis B and human immunodeficiency virus. It offers aseptic filling, plasma fractionation and pharmaceutical compounding, as well as extraction, concentration and purification services for complex molecules. Talecris Biotherapeutics sponsors external research grant programs.